Form D Friday: Dallas biotech firm raises $44M to fight ovarian cancer


Dallas cancer drug maker Gradalis, which is run by the former president of the Mary Crowley Cancer Research Centers, has raised nearly $44 million.

Previous Clearwater cybersecurity company is a funding standout in Florida
Next TBJ Data Dance: Inside the Triangle M&A list

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *